Shares of Evertec jumped 10.9% to $34.61 in early trading November 4 after the Puerto Rico-based payments company posted a third-quarter earnings beat and — for the third consecutive quarter — raised its full-year outlook. The question investors now face: how much of the acceleration is organic, and how much is acquisition-fueled?
A Big Beat That Wasn't Priced In
Revenue hit $283 million, up 24% year-over-year, while adjusted earnings per share of $1.07 topped the $0.98 Wall Street consensus by nearly a dime.
The stock had actually closed down 4.5% the prior session at $31.26, suggesting the market was cautious heading into the print — making today's reversal all the more striking.
Latin America Is Now Half the Business — and the Margin Risk
Nearly half of Evertec's revenue now comes from outside Puerto Rico, reflecting a decade-long geographic transformation.
The Latin America payments segment delivered revenue growth of 59% (52% in constant currency) with adjusted EBITDA up 77%. But that expansion comes at a cost: company-wide adjusted EBITDA margin compressed 150 basis points to 39.0% — meaning the company kept less of each revenue dollar as profit. Investors need to watch whether scale in Latin America eventually pushes margins back up or permanently dilutes them.
Guidance Raised for the Third Time This Year
Management now expects $1.088–$1.096 billion in 2026 revenue, implying 16.7%–17.6% growth. That's up from the Q2 range of $1.085–$1.095 billion and the Q1 range of $1.073–$1.085 billion . Adjusted EPS guidance climbed to $4.00–$4.08, compared with $3.62 earned in full-year 2025 . At today's price, the stock trades at roughly 8.5x the midpoint of that EPS range — cheap for a mid-teens grower.
Acquisitions Are Doing Heavy Lifting — and That Has Limits
Evertec completed the acquisition of BBChain in Q3, adding blockchain and digital-asset capabilities , following the Dimensa deal in Q1 and strategic agreements with Transbank in Chile and Clip in Mexico in Q2 . No acquisition synergies are baked into the 2026 guidance; expense and revenue synergies are expected in 2027–2028. That leaves upside if integration delivers — but raises execution risk across multiple simultaneous deals. The valuation discount won't close until organic growth proves it can carry the story alone.